Published in Oligonucleotides on June 01, 2009
Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression. Br J Cancer (2010) 1.16
Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes. Mol Pharm (2011) 0.95
Recent developments in nanoparticle-based siRNA delivery for cancer therapy. Biomed Res Int (2013) 0.92
Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells. J Nanobiotechnology (2015) 0.91
Enhanced intrapulmonary delivery of anticancer siRNA for lung cancer therapy using cationic ethylphosphocholine-based nanolipoplexes. Mol Ther (2013) 0.87
Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells. J Drug Deliv (2013) 0.85
Application of Collagen-Model Triple-Helical Peptide-Amphiphiles for CD44-Targeted Drug Delivery Systems. J Drug Deliv (2012) 0.82
Ligand-targeted theranostic nanomedicines against cancer. J Control Release (2016) 0.77
Fluorescence and electron microscopy to visualize the intracellular fate of nanoparticles for drug delivery. Eur J Histochem (2016) 0.76
International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol Rev (2006) 1.60
Lectin-mediated drug targeting: history and applications. Adv Drug Deliv Rev (2004) 1.59
Nanoparticles--an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm (2006) 1.56
Nanocapsule technology: a review. Crit Rev Ther Drug Carrier Syst (2002) 1.46
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs. J Control Release (2004) 1.44
Cracking the estrogen receptor's posttranslational code in breast tumors. Endocr Rev (2011) 1.39
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. J Control Release (2003) 1.38
Differentiation of human alveolar epithelial cells in primary culture: morphological characterization and synthesis of caveolin-1 and surfactant protein-C. Cell Tissue Res (2002) 1.33
Squalenoyl nanomedicines as potential therapeutics. Nano Lett (2006) 1.28
Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity. Mol Pharm (2007) 1.28
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv Drug Deliv Rev (2003) 1.25
Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomedicine (2007) 1.21
Estrogen receptor signaling as a target for novel breast cancer therapeutics. Biochem Pharmacol (2012) 1.18
Binding of hsp90-associated immunophilins to cytoplasmic dynein: direct binding and in vivo evidence that the peptidylprolyl isomerase domain is a dynein interaction domain. Biochemistry (2002) 1.18
Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. Adv Drug Deliv Rev (2006) 1.18
Towards an in vitro model of cystic fibrosis small airway epithelium: characterisation of the human bronchial epithelial cell line CFBE41o-. Cell Tissue Res (2005) 1.15
Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers. J Control Release (2006) 1.13
Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access. Mol Pharm (2010) 1.13
The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. PLoS One (2012) 1.11
Encapsulation of dexamethasone into biodegradable polymeric nanoparticles. Int J Pharm (2006) 1.08
Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol (2009) 1.06
Interaction of metal oxide nanoparticles with lung surfactant protein A. Eur J Pharm Biopharm (2010) 1.04
Relevance of the colloidal stability of chitosan/PLGA nanoparticles on their cytotoxicity profile. Int J Pharm (2009) 1.04
Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile. Vaccine (2007) 1.04
Liquid perfluorocarbons as contrast agents for ultrasonography and (19)F-MRI. Pharm Res (2009) 1.04
Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucus. Proc Natl Acad Sci U S A (2012) 1.03
Selective follicular targeting by modification of the particle sizes. J Control Release (2010) 1.03
Downregulation of endotoxin-induced uveitis by intravitreal injection of vasoactive intestinal Peptide encapsulated in liposomes. Invest Ophthalmol Vis Sci (2007) 1.03
Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery. Expert Opin Drug Deliv (2004) 1.02
Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid. J Control Release (2008) 1.02
Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A. Nanomedicine (2011) 1.02
New novobiocin analogues as antiproliferative agents in breast cancer cells and potential inhibitors of heat shock protein 90. J Med Chem (2007) 1.01
Synthesis and biological activity of simplified denoviose-coumarins related to novobiocin as potent inhibitors of heat-shock protein 90 (hsp90). Bioorg Med Chem Lett (2008) 0.99
State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers. Int J Pharm (2008) 0.99
In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer. Eur J Pharm Sci (2006) 0.98
Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules. Int J Pharm (2007) 0.98
p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells. Cancer Res (2003) 0.98
Differential cell reaction upon Toll-like receptor 4 and 9 activation in human alveolar and lung interstitial macrophages. Respir Res (2010) 0.97
P-glycoprotein (MDR1) functional activity in human alveolar epithelial cell monolayers. Cell Tissue Res (2006) 0.97
Human skin penetration of flufenamic acid: in vivo/in vitro correlation (deeper skin layers) for skin samples from the same subject. J Invest Dermatol (2002) 0.97
Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma. Pharm Res (2006) 0.96
Depletion of alveolar macrophages by clodronate-liposomes aggravates ischemia-reperfusion injury of the lung. J Heart Lung Transplant (2005) 0.96
Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa: a first in vivo study in human patients. J Control Release (2012) 0.96
Liposomes for intravitreal drug delivery: a state of the art. J Control Release (2012) 0.95
Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells. Mol Pharm (2009) 0.95
Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma. J Steroid Biochem Mol Biol (2005) 0.95
A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro. Mol Pharm (2010) 0.95
Expression of microphthalmia-associated transcription factor (MITF), which is critical for melanoma progression, is inhibited by both transcription factor GLI2 and transforming growth factor-β. J Biol Chem (2012) 0.94
Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice. Eur J Pharm Biopharm (2005) 0.94
Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa. J Control Release (2012) 0.94
Role of gut macrophages in mice orally contaminated with scrapie or BSE. Int J Pharm (2005) 0.93
Coupling of biotin-(poly(ethylene glycol))amine to poly(D,L-lactide-co-glycolide) nanoparticles for versatile surface modification. Bioconjug Chem (2007) 0.93
Nanoparticle geometry and surface orientation influence mode of cellular uptake. ACS Nano (2013) 0.93
Large porous particle impingement on lung epithelial cell monolayers--toward improved particle characterization in the lung. Pharm Res (2003) 0.92
Permeability of the reconstructed human epidermis model Episkin in comparison to various human skin preparations. Eur J Pharm Biopharm (2006) 0.92
Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation. J Control Release (2005) 0.92
Mucus as a barrier to lipophilic drugs. Int J Pharm (2013) 0.92
Removal of residual colonic ciprofloxacin in the rat by activated charcoal entrapped within zinc-pectinate beads. Eur J Pharm Sci (2010) 0.92
Folate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase system. Int J Pharm (2009) 0.92
Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nanoprecipitation. Int J Pharm (2007) 0.91
Dexamethasone acetate encapsulation into Trojan particles. J Control Release (2008) 0.91
The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent. Biomaterials (2009) 0.91
Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. Int J Nanomedicine (2011) 0.91
Hyaluronic acid-coated liposomes for active targeting of gemcitabine. Eur J Pharm Biopharm (2013) 0.91
Potential pitfalls in skin permeation experiments: influence of experimental factors and subsequent data evaluation. Eur J Pharm Biopharm (2008) 0.90
All of the protein interactions that link steroid receptor.hsp90.immunophilin heterocomplexes to cytoplasmic dynein are common to plant and animal cells. Biochemistry (2002) 0.90
Evaluation of critical formulation parameters influencing the bioactivity of beta-lactamases entrapped in pectin beads. Int J Pharm (2006) 0.90
Intravitreal delivery of oligonucleotides by sterically stabilized liposomes. Invest Ophthalmol Vis Sci (2002) 0.90
Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. Eur J Pharm Sci (2011) 0.90
Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis. J Ocul Pharmacol Ther (2009) 0.89
A new paradigm for high-sensitivity 19F magnetic resonance imaging of perfluorooctylbromide. Magn Reson Med (2010) 0.89
An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier. Eur J Pharm Biopharm (2010) 0.89
Cellular responses after exposure of lung cell cultures to secondary organic aerosol particles. Environ Sci Technol (2010) 0.89